Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder.
Chiu
Chih-Chiang
CC
Huang
Shih-Yi
SY
Chen
Chiao-Chicy
CC
Su
Kuan-Pin
KP
D000208:Acute Disease; D000927:Anticonvulsants / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D010919:Placebos; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D016896:Treatment Outcome; D014635:Valproic Acid / Q000627:therapeutic use
D000927:Anticonvulsants; D015525:Fatty Acids, Omega-3; D010919:Placebos; D014635:Valproic Acid